Symptoms and Endoscopic Results in Consideration of Pretreatment - Tabular View

Tracking Information

First Received Date ^ICMJE

January 28, 2008

Last Updated Date

February 8, 2008

Start Date ^ICMJE

September 2005

Primary Completion Date

December 2005 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

to gain insight into the relationship between subjective gastrointestinal symptoms and findings of a laryngopharyngeal-esophagogastric endoscopy with respect to the medicinal pre-therapy;

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00612404 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

to gain insight into the currently used treatment strategies with esomeprazole depending on endoscopic findings.

Original Secondary Outcome Measures ^ICMJE

Same as current

Descriptive Information

Brief Title ^ICMJE

Symptoms and Endoscopic Results in Consideration of Pretreatment

Official Title ^ICMJE

Symptoms and Endoscopic Results in Consideration of Pretreatment

Brief Summary

Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. gastroenterologists) are asked to document relevant data in patients with gastrointestinal disorders.

Detailed Description

Study Phase

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Cohort, Prospective

Condition ^ICMJE

Gastrointestinal Diseases

Intervention ^ICMJE

Study Arms / Comparison Groups

patients with gastrointestinal disorders who need an endoscopy.

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

16255

Completion Date

Primary Completion Date

December 2005 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

patients with gastrointestinal disorders who need an endoscopy.

Exclusion Criteria:

limitiations; possible risks; warnings; contraindications mentioned in the SPC.

Gender

Both

Ages

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

Administrative Information

NCT ID ^ICMJE

NCT00612404

Responsible Party

Dr Kai Richter, AstraZeneca Germany

Study ID Numbers ^ICMJE

1312004008

Study Sponsor ^ICMJE

AstraZeneca

Collaborators ^ICMJE

Investigators ^ICMJE

Study Chair:

Kai Richter, MD

Medical Department AstraZeneca Germany

Information Provided By

AstraZeneca

Verification Date

January 2008

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP